Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada.

While treatment uptake has increased with the availability of second-generation DAAs, marginalized populations, already engaged in care, are still failing to access treatment. Targeted strategies to address barriers are needed to avoid further health inequities and to maximize the public health impact of DAAs.